Last reviewed · How we verify
RegStem
At a glance
| Generic name | RegStem |
|---|---|
| Also known as | MSC |
| Sponsor | EMO Biomedicine Corporation |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RegStem CI brief — competitive landscape report
- RegStem updates RSS · CI watch RSS
- EMO Biomedicine Corporation portfolio CI